- Home
- BPOP vs JAZZ Comparison
BPOP vs JAZZ Comparison
Compare BPOP & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPOP
- JAZZ
- Stock Information
- Founded
- BPOP 1893
- JAZZ 2003
- Country
- BPOP United States
- JAZZ Ireland
- Employees
- BPOP N/A
- JAZZ N/A
- Industry
- BPOP Major Banks
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- BPOP Finance
- JAZZ Health Care
- Exchange
- BPOP Nasdaq
- JAZZ Nasdaq
- Market Cap
- BPOP 7.2B
- JAZZ 6.7B
- IPO Year
- BPOP N/A
- JAZZ 2007
- Fundamental
- Price
- BPOP $114.64
- JAZZ $109.89
- Analyst Decision
- BPOP Buy
- JAZZ Strong Buy
- Analyst Count
- BPOP 6
- JAZZ 12
- Target Price
- BPOP $114.50
- JAZZ $183.08
- AVG Volume (30 Days)
- BPOP 553.3K
- JAZZ 652.3K
- Earning Date
- BPOP 07-23-2025
- JAZZ 07-30-2025
- Dividend Yield
- BPOP 2.47%
- JAZZ N/A
- EPS Growth
- BPOP 43.88
- JAZZ 49.21
- EPS
- BPOP 9.68
- JAZZ 7.51
- Revenue
- BPOP $2,735,868,000.00
- JAZZ $4,064,808,000.00
- Revenue This Year
- BPOP N/A
- JAZZ $6.05
- Revenue Next Year
- BPOP $6.82
- JAZZ $4.68
- P/E Ratio
- BPOP $11.72
- JAZZ $14.62
- Revenue Growth
- BPOP 6.94
- JAZZ 5.76
- 52 Week Low
- BPOP $78.23
- JAZZ $95.49
- 52 Week High
- BPOP $113.70
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- BPOP 77.79
- JAZZ 53.40
- Support Level
- BPOP $109.76
- JAZZ $105.26
- Resistance Level
- BPOP $109.66
- JAZZ $111.25
- Average True Range (ATR)
- BPOP 1.89
- JAZZ 2.50
- MACD
- BPOP 0.66
- JAZZ 0.22
- Stochastic Oscillator
- BPOP 97.58
- JAZZ 77.70
About BPOP Popular Inc.
Popular Inc, based in Puerto Rico, is a financial holding company with four main subsidiaries: Banco Popular de Puerto Rico, a bank in Puerto Rico in terms of assets; Banco Popular North America, its banking operation in the continental United States; Evertec, a data processor; and Popular Financial Holdings, a diversified financial services company. The Corporation's reportable segments consist of Banco Popular de Puerto Rico and Popular U.S.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.